$52.48
+0 (+0%)
At Close: May 27, 2022
Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5 Billion in Cash
05:40pm, Wednesday, 19'th Aug 2020
Johnson & Johnson (NYSE: JNJ) just took a big step into the field of immunology with a $6.5 billion deal for Momenta Pharmaceuticals (NASDAQ: MNTA). On Tuesday, the giant healthcare conglomerate anno
US STOCKS-S&P 500, Nasdaq hit record highs as Apple crosses $2 trillion mark
05:17pm, Wednesday, 19'th Aug 2020
The S&P 500 and the Nasdaq indexes hit all-time highs on Wednesday as Apple became the first publicly listed U.S. company to cross $2 trillion in market capitalization, with strong results from retail
Could Momenta Deal Give Johnson & Johnson Breakout Momentum?
05:05pm, Wednesday, 19'th Aug 2020
Johnson & Johnson will buy Momenta for $6.5 billion in an all-cash deal. That's not disrupting the chart though, which has breakout potential for the stock.
MOMENTA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
04:59pm, Wednesday, 19'th Aug 2020
WILMINGTON, Del., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Momenta Pharmaceuticals, Inc. (“Momenta”) (NASDAQ GS: MNTA) regarding possible breache
MOMENTA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MNTA and Encourages Investors to Contact the Firm
04:52pm, Wednesday, 19'th Aug 2020
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) breached
Stocks making the biggest moves midday: Target, Apple, Momenta, BioMarin & more
04:10pm, Wednesday, 19'th Aug 2020
Check out the companies making headlines in midday trading.
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Momenta Pharmaceuticals, Inc.
US STOCKS-S&P 500, Nasdaq hit record highs as Apple tops $2 trillion in market value
03:35pm, Wednesday, 19'th Aug 2020
The S&P 500 and Nasdaq indexes hit all-time highs on Wednesday as Apple became the first publicly listed U.S. company to cross $2 trillion in market capitalization, with strong results from retailers
ROCE Insights For Momenta Pharmaceuticals
03:33pm, Wednesday, 19'th Aug 2020
During Q2, Momenta Pharmaceuticals's (NASDAQ: MNTA) reported sales totaled $6.61 million. Despite a 41.09% in earnings, the company posted a loss of $57.38 million. Momenta Pharmaceuticals collected $
Johnson & Johnson -- Moody's affirms J&J's Aaa rating; negative outlook
03:27pm, Wednesday, 19'th Aug 2020
Moody's Investors Service ("Moody's") affirmed the Aaa long-term ratings of Johnson & Johnson ("J&J"), as well as the Prime-1 short-term rating. The rating affirmation follows the announcement that J
Johnson & Johnson Is Buying Momenta Pharmaceuticals. Both Stocks Are Gaining.
03:22pm, Wednesday, 19'th Aug 2020
(JNJ) said Wednesday morning it had agreed to buy the biotech firm (MNTA) in an all-cash $6.5 billion deal, acquiring rights to Momenta’s experimental drug nipocalimab, which has potential uses in
Stocks move modestly higher, S&P 500 clinches new intraday high
02:47pm, Wednesday, 19'th Aug 2020
U.S. stocks saw subdued but slightly higher trade early Wednesday, a day after the S&P 500 index scored its first record close in six months, with that all-time high marking a historic comeback for th
US STOCKS-S&P 500 notches record high for second day after Target, Lowe's results beat
02:15pm, Wednesday, 19'th Aug 2020
The S&P 500 and Nasdaq scaled record highs on Wednesday as results from retailers Target and Lowe's trounced estimates, a day after the S&P 500 completed its fastest recovery ever from a bear market.
Johnson & Johnson Buys Biotech Momenta Pharmaceuticals for $6.5 Billion
12:46pm, Wednesday, 19'th Aug 2020
(JNJ) said Wednesday morning it had agreed to buy the biotech firm (MNTA) in an all-cash $6.5 billion deal, acquiring rights to Momenta’s experimental drug nipocalimab, which has potential uses in
US STOCKS-Wall St set to open higher after solid results from Lowe's, Target
12:44pm, Wednesday, 19'th Aug 2020
Futures pointed to slim opening gains for Wall Street's main indexes on Wednesday following results from retailers Target and Lowe's that trounced estimates, a day after the S&P 500 completed its fast
Sign In
Buy MNTA